IDS Antikörper
-
- Target Alle IDS Antikörper anzeigen
- IDS (Iduronate 2-Sulfatase (IDS))
-
Reaktivität
- Human, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser IDS Antikörper ist unkonjugiert
-
Applikation
- Immunohistochemistry (IHC), ELISA
- Produktmerkmale
- Polyclonal Antibody
- Aufreinigung
- Antigen affinity purification
- Immunogen
- Fusion protein of human IDS
- Isotyp
- IgG
- Top Product
- Discover our top product IDS Primärantikörper
-
-
- Applikationshinweise
- IHC 1:50-1:200, ELISA 1:5000-1:10000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1.02 mg/mL
- Buffer
- PBS with 0.05 % Sodium azide and 40 % Glycerol, pH 7.4
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- IDS (Iduronate 2-Sulfatase (IDS))
- Andere Bezeichnung
- IDS (IDS Produkte)
- Synonyme
- mps2 antikoerper, sids antikoerper, zgc:158245 antikoerper, MPS2 antikoerper, SIDS antikoerper, AW214631 antikoerper, iduronate 2-sulfatase antikoerper, IDS antikoerper, CpipJ_CPIJ004938 antikoerper, ids antikoerper, Ids antikoerper
- Hintergrund
- Iduronate 2-sulfatase (IDS) is required for the lysosomal degradation of heparan sulfate and dermatan sulfate. Mutations causing IDS deficiency in humans result in the lysosomal storage of these glycosaminoglycans and Hunter syndrome,an X chromosome-linked disease. An internal proteolytic cleavage occurs to produce the mature IDS present in human liver shown to contain a 42 kDa polypeptide N-terminal to a 14 kDa polypeptide..
- UniProt
- P22304
- Pathways
- Glycosaminoglycan Metabolic Process
-